Finance, mergers and appointments

Bayer plans state-of-the-art R&D site in New Albany, Ohio, USA

Bayer plans to build a state-of-the-art site in New Albany, Ohio, USA, to serve local patients as well as globally. Bayer expects to create around...

US $1 billion investment will grow AstraZeneca’s workforce in Massachusetts by over 50% and deliver next-generation medicines 

AstraZeneca has opened a new global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, USA. The new state-of-the-art facility builds on the...

Consano Bio raises more than US $15 million in oversubscribed financing to advance C-1101 in chronic painful lumbosacral radiculopathy (chronic sciatica)

Consano Bio, a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopaedic conditions, has completed an oversubscribed financing, raising more than its...

CellCarta establishes strategic partnership with Waters to advance companion diagnostics development

CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a global leader in life sciences...

Ontario contributes $1.7 million investment to advance life sciences innovation at Piramal Pharma’s Aurora facility

Piramal Pharma Solutions (PPS), a leading global contract development and manufacturing organisation (CDMO) has announced that its Aurora, Canada drug substance site has received a...

Evotec announces Chief Scientific Officer transition

Chief Scientific Officer of Evotec SE, Dr Cord Dohrmann, will step down effective 30 September. The decision for Dr Dohrmann to step down from his...

Alcami strengthens commercial operations with appointment of Will Isom as Vice President of laboratory services sales

Alcami, a leading contract development and manufacturing organisation (CDMO), has appointed biologics industry veteran Will Isom as Vice President of Laboratory Services Sales. The creation...

Vertex Completes acquisition of Crinetics Pharmaceuticals and announces expansion of executive leadership team

Vertex Pharmaceuticals has successfully acquired Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development and commercialisation of novel therapeutics for endocrine diseases. Vertex also...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -

Latest stories